Long term treatment of duodenal ulcer. A review of management options
- PMID: 1706986
- DOI: 10.2165/00003495-199141010-00004
Long term treatment of duodenal ulcer. A review of management options
Abstract
Duodenal ulcer is a chronic disease characterised by remission and relapses. The duration of this relapsing tendency is unpredictable for the individual patient, but in most cases it lasts for many years and perhaps the entire lifetime. Various therapeutic strategies have been suggested to maintain the disease in remission: continuous, intermittent and on-demand treatment with H2-antagonists, or surgery. Continuous maintenance treatment with the currently available H2-blockers has proved to be superior to all the other strategies in terms of efficacy, and should therefore be regarded as the long term treatment of choice for duodenal ulcer patients. The duration of maintenance treatment is still uncertain, but probably it should not be less than a few years. Intermittent treatment or surgery could be proposed to patients unsuitable for continuous maintenance, depending on whether they have mild or aggressive disease, respectively.
Similar articles
-
Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.Yale J Biol Med. 1996 May-Jun;69(3):211-24. Yale J Biol Med. 1996. PMID: 9165690 Free PMC article. Review.
-
Prevention of duodenal ulcer recurrence.Ann Intern Med. 1986 Nov;105(5):757-61. doi: 10.7326/0003-4819-105-5-757. Ann Intern Med. 1986. PMID: 2876669 Review.
-
'Difficult' duodenal ulcer patients: clinical and therapeutic problems.Dig Dis. 1991;9(4):219-28. doi: 10.1159/000171306. Dig Dis. 1991. PMID: 1680585 Review. No abstract available.
-
Intermittent treatment of duodenal ulcer for long term medical management.Postgrad Med J. 1988;64 Suppl 1:40-6. Postgrad Med J. 1988. PMID: 2901744 Review.
-
H2-receptor antagonists and duodenal ulcer recurrence: analysis of efficacy and commentary on safety, costs, and patient selection.Am J Gastroenterol. 1987 Dec;82(12):1242-9. Am J Gastroenterol. 1987. PMID: 2891294 Clinical Trial.
Cited by
-
Optimizing acid suppression for treatment of acid-related diseases.Dig Dis Sci. 1995 Feb;40(2 Suppl):24S-49S. doi: 10.1007/BF02214870. Dig Dis Sci. 1995. PMID: 7859582 Review.
-
Ranitidine: a pharmacoeconomic evaluation of its use in acid-related disorders.Pharmacoeconomics. 1994 Jul;6(1):57-89. doi: 10.2165/00019053-199406010-00007. Pharmacoeconomics. 1994. PMID: 10147354 Review.
-
The use of proprietary medicines by patients presenting with peptic ulcer haemorrhage.Br J Clin Pharmacol. 1993 May;35(5):451-4. doi: 10.1111/j.1365-2125.1993.tb04168.x. Br J Clin Pharmacol. 1993. PMID: 8512756 Free PMC article.
-
Prescribing policy for antiulcer treatment in the elderly.Drugs Aging. 1993 Jul-Aug;3(4):308-19. doi: 10.2165/00002512-199303040-00002. Drugs Aging. 1993. PMID: 8369591 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources